Results 51 to 60 of about 109,766 (337)

Rilonacept (Interleukin-1 Inhibition) for the Treatment of Pericarditis

Current Cardiology Reports, 2022
Purpose of Review We reviewed the contemporary literature and clinical trials to discuss the applications of the interleukin-1 (IL-1) inhibitor rilonacept to treat pericarditis, with regards to pathophysiology, pharmacology, efficacy, and safety.
T. Wang, Allan L. Klein
semanticscholar   +1 more source

Three-year outcomes of a once daily fractionation scheme for accelerated partial breast irradiation (APBI) using 3-D conformal radiotherapy (3D-CRT). [PDF]

, 2013
The aim of this study was to report 3-year outcomes of toxicity, cosmesis, and local control using a once daily fractionation scheme (49.95 Gy in 3.33 Gy once daily fractions) for accelerated partial breast irradiation (APBI) using three-dimensional ...
Daroui, Parima, Goyal, Sharad, Haffty, Bruce G, Kearney, Thomas, Khan, Atif J, Kirstein, Laurie   +5 more
core   +2 more sources

Pericardial effusion caused by viral pericarditis in a patient receiving peritoneal dialysis

Renal Replacement Therapy, 2022
Background Acute pericarditis causes acute inflammation of the pericardium. Although most cases of pericarditis are idiopathic with no identifiable cause, its etiology can be infectious, such as viral, bacterial, mycotic, and tuberculous infections, or ...
Masahiro Egawa, Shungo Fujii, Kentaro Takase, Ryuichi Yoshimura, Asuka Yamauchi, Kaori Yoshikane, Kazuaki Tanabe, Hiroaki Shiina, Takafumi Ito   +8 more
doaj   +1 more source

Immunomodulating Therapies in Acute Myocarditis and Recurrent/Acute Pericarditis

Frontiers in Medicine, 2022
The field of inflammatory disease of the heart or “cardio-immunology” is rapidly evolving due to the wider use of non-invasive diagnostic tools able to detect and monitor myocardial inflammation.
E. Ammirati, E. Bizzi, G. Veronese, M. Groh, C. M. Van de Heyning, J. Lehtonen, Marc Pineton de Chambrun, A. Cereda, C. Picchi, L. Trotta, J. Moslehi, A. Brucato   +11 more
semanticscholar   +1 more source

Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID‐19 patients

European Journal of Clinical Investigation, 2021
COVID‐19 has a wide spectrum of cardiovascular sequelae including myocarditis and pericarditis; however, the prevalence and clinical impact are unclear.
B. Buckley, S. Harrison, Elnara Fazio-Eynullayeva, P. Underhill, D. Lane, G. Lip   +5 more
semanticscholar   +1 more source

Pericarditis constrictiva: multimodalidad

Revista Colombiana de Cardiología, 2019
Resumen: La pericarditis constrictiva es una entidad clínica que se manifiesta con signos y síntomas de insuficiencia cardiaca diastólica, causada por un pericardio anormalmente engrosado y rígido, o ambos, y disminución consecuente del llenado ...
Renato Quispe, Pedro A. Villablanca, Mario García   +2 more
doaj   +1 more source

Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients

Vaccines, 2021
Myocarditis and pericarditis have been linked recently to COVID-19 vaccines without exploring the underlying mechanisms, or compared to cardiac adverse events post-non-COVID-19 vaccines.
Rima Hajjo, D. Sabbah, S. Bardaweel, A. Tropsha   +3 more
semanticscholar   +1 more source

Outbreak of encephalitic listeriosis in red-legged partridges (Alectoris rufa) [PDF]

, 2015
An outbreak of neurological disease was investigated in red-legged partridges between 8 and 28 days of age. Clinical signs included torticollis, head tilt and incoordination and over an initial eight day period approximately 30–40 fatalities occurred per
Barnes H.J., Basher H.A., Fonnesbech Vogel B., Gitter M., Ivanics E., Lucas A., McDiarmid A., McKellar R.C., Okwumabua O.E., Paterson J.S., Paterson J.S., Seeliger H.P., Vaissaire J., Vijayakrishna S.   +13 more
core   +1 more source

Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types

Journal of Personalized Medicine, 2021
An increasing number of myocarditis/pericarditis incidences has been reported after coronavirus disease-19 (COVID-19) vaccination in adolescents and young adults.
M. Li, Jing Yuan, G. Lv, Jacob Brown, Xiangxiang Jiang, Z. Lu   +5 more
semanticscholar   +1 more source

Disentangling a Thorny Issue: Myocarditis and Pericarditis Post COVID-19 and Following mRNA COVID-19 Vaccines

Pharmaceuticals, 2022
Considering the clinical significance for myocarditis and pericarditis after immunization with mRNA COVID-19 vaccines, the present pharmacovigilance study aimed to describe these events reported with mRNA COVID-19 vaccines in the Vaccine Adverse Events ...
Concetta Rafaniello, Mario Gaio, Alessia Zinzi, Maria Giuseppa Sullo, Valerio Liguori, Marialuisa Ferraro, Fiorella Petronzelli, Patrizia Felicetti, Pasquale Marchione, Anna Rosa Marra, Francesco Rossi, Antonella De Angelis, Annalisa Capuano   +12 more
doaj   +1 more source